What's New

Clinical Impact: Perioperative Monitoring During TCAR Procedure

Every year nearly 800,000 people in the US have a stroke. Around 10 to 20 percent of strokes are due to carotid artery disease and more than 100,000 carotid revascularization procedures are performed every year. Without the help of cerebral blood flow monitoring, inadequate blood supply, dangerous embolization, and hyperperfusion can go unseen by the surgical team. Download the case to learn how the real-time blood flow data provided by the NovaSignal Platform allows clinicians to immediately respond to perioperative concerns.

TCD Offers Hope for Children with Sickle Cell Disease

More than 75% of the global burden of SCD occurs in sub-Saharan Africa, where an estimated 1.03 million children are afflicted. Learn more about how Dr. Nicole O’Brien and Nationwide Children’s Hospital is using TCD to help treat SCD in Africa!

New Enhancements to NovaSignal Platform Enable Remote Monitoring and Boost Telehealth Capabilities

With new live exam streaming capabilities, hospitals can expedite patient assessment and triage by quickly connecting patients with clinical specialists within the hospital or across the health system. Members of the clinical team can now remotely monitor vessel velocities and emboli count in real time, while automatic notifications on key events improve team coordination.

New Research - Cerebral Microembolic Signal Burden During Pulsed Filed Ablation: Preliminary Results from Robotically Assisted Transcranial Doppler

Transcranial Doppler (TCD) has been used to monitor the burden of cerebral microembolic signals (MESs) during atrial fibrillation (AF) ablation. MES burden is considered a surrogate marker for stroke risk and has never been reported during AF ablation with the novel pulsed field ablation (PFA) system.

Want to learn more? Get in touch!